These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27256109)

  • 1. Induction chemotherapy for head and neck squamous cell carcinoma.
    T Parsons J; D Greene B
    Oral Oncol; 2016 Jul; 58():e12. PubMed ID: 27256109
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of Induction Chemotherapy Prior to Chemoradiation in Head and Neck Squamous Cell Cancer-Systematic Review and Meta-analysis.
    Vidal L; Ben Aharon I; Limon D; Cohen E; Popovtzer A
    Cancer J; 2017; 23(2):79-83. PubMed ID: 28410291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation.
    Ock CY; Keam B; Kim TM; Han DH; Won TB; Lee SH; Hah JH; Kwon TK; Kim DW; Kim DY; Rhee CS; Wu HG; Sung MW; Heo DS
    Korean J Intern Med; 2016 May; 31(3):570-8. PubMed ID: 26976150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of induction chemotherapy for head and neck squamous cell carcinoma.
    Haigentz M; Cohen EE; Wolf GT; Strojan P; Eisbruch A; Ferlito A
    Oral Oncol; 2012 Nov; 48(11):1065-7. PubMed ID: 22981388
    [No Abstract]   [Full Text] [Related]  

  • 5. Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: value of FDG volumetric imaging parameters.
    Yu J; Cooley T; Truong MT; Mercier G; Subramaniam RM
    J Med Imaging Radiat Oncol; 2014 Feb; 58(1):18-24. PubMed ID: 24529051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival impact of induction chemotherapy in advanced head and neck cancer: A National Cancer Database analysis.
    Stokes WA; Amini A; Jones BL; McDermott JD; Raben D; Ghosh D; Goddard JA; Bowles DW; Karam SD
    Head Neck; 2017 Jun; 39(6):1113-1121. PubMed ID: 28301079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiation.
    Ko EC; Genden EM; Misiukiewicz K; Som PM; Kostakoglu L; Chen CT; Packer S; Kao J
    Oncol Rep; 2012 Feb; 27(2):467-74. PubMed ID: 22020564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target volume delineation after induction chemotherapy in locally advanced head and neck cancer.
    De Felice F; Musio D; Tombolini V
    Oral Oncol; 2015 Nov; 51(11):e81. PubMed ID: 26387077
    [No Abstract]   [Full Text] [Related]  

  • 9. May we rely on induction chemotherapy again as a biological selection of radiosensitive head and neck cancer?
    Bossi P; Seront E; Machiels JP
    Oral Oncol; 2019 Jul; 94():121-122. PubMed ID: 31126715
    [No Abstract]   [Full Text] [Related]  

  • 10. nab-Paclitaxel-based induction chemotherapy with or without cetuximab for locally advanced head and neck squamous cell carcinoma.
    Adkins D; Ley J; Oppelt P; Wildes TM; Gay HA; Daly M; Rich J; Paniello RC; Jackson R; Pipkorn P; Nussenbaum B; Trinkaus K; Thorstad W
    Oral Oncol; 2017 Sep; 72():26-31. PubMed ID: 28797458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction chemotherapy in head and neck cancer: are we too ambitious?
    Specenier P
    Future Oncol; 2014 Feb; 10(3):337-40. PubMed ID: 24559441
    [No Abstract]   [Full Text] [Related]  

  • 12. Locally advanced squamous cell carcinoma of the head and neck: CT texture and histogram analysis allow independent prediction of overall survival in patients treated with induction chemotherapy.
    Zhang H; Graham CM; Elci O; Griswold ME; Zhang X; Khan MA; Pitman K; Caudell JJ; Hamilton RD; Ganeshan B; Smith AD
    Radiology; 2013 Dec; 269(3):801-9. PubMed ID: 23912620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck.
    Keil F; Selzer E; Berghold A; Reinisch S; Kapp KS; De Vries A; Greil R; Bachtiary B; Tinchon C; Anderhuber W; Burian M; Kasparek AK; Elsäßer W; Kainz H; Riedl R; Kopp M; Kornek G
    Eur J Cancer; 2013 Jan; 49(2):352-9. PubMed ID: 22981499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy with docetaxel, cisplatin and capecitabine, followed by combined cetuximab and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck: a phase I-II study.
    Perri F; Muto P; Argenone A; Ionna F; Longo F; Fulciniti F; Sandomenico F; Daponte A; Caponigro F
    Oncology; 2013; 84(4):251-4. PubMed ID: 23428719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status.
    Lowe NM; Bernstein JM; Mais K; Garcez K; Lee LW; Sykes A; Thomson DJ; Homer JJ; West CM; Slevin NJ
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):389-401. PubMed ID: 29222650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Cetuximab in combination with radiotherapy or chemotherapy against advanced squamous cell carcinoma of the head and neck.
    Li JZ; Zheng JW; Zhang ZY
    Shanghai Kou Qiang Yi Xue; 2008 Feb; 17(1):1-5. PubMed ID: 18360658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Betel nut chewing history is an independent prognosticator for smoking patients with locally advanced stage IV head and neck squamous cell carcinoma receiving induction chemotherapy with docetaxel, cisplatin, and fluorouracil.
    Su YY; Chien CY; Luo SD; Huang TL; Lin WC; Fang FM; Chiu TJ; Chen YH; Lai CC; Hsu CM; Li SH
    World J Surg Oncol; 2016 Mar; 14():86. PubMed ID: 27001663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemotherapy with cisplatin and ifosfamide in locally advanced inoperable squamous cell carcinoma of the head and neck: A single-institution experience.
    Zaheer S; Siddiqui SA; Akram M; Hasan SA
    Indian J Cancer; 2016; 53(3):372-376. PubMed ID: 28244461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase 1 study of nab-paclitaxel, cisplatin and 5-fluorouracil as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced squamous cell carcinoma of the oropharynx.
    Loong HH; Winquist E; Waldron J; Chen EX; Kim J; Palma D; Read N; Razak AR; Diaz-Padilla I; Chan K; Bayley A; Hossain M; Wang L; Chin S; Siu LL; Hope A
    Eur J Cancer; 2014 Sep; 50(13):2263-70. PubMed ID: 24953566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In squamous cell head and neck cancer: which platinum, how much and how often?
    Nwizu T; Adelstein DJ
    Expert Rev Anticancer Ther; 2014 Sep; 14(9):1033-9. PubMed ID: 24998393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.